Download Files:
KW-8232 free base
SKU
HY-100304-1 mg
Category Reference compound
Tags Anti-infection;GPCR/G Protein, Metabolic Disease; Endocrinology, Prostaglandin Receptor;SARS-CoV
$850
Only 1000 item(s) left in stock.
Products Details
Product Description
– KW-8232 free base, an orally active anti-osteoporotic agent, and can reduces the biosynthesis of PGE2[1].
Web ID
– HY-100304
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Metabolism-protein/nucleotide metabolism
Molecular Formula
– C36H37ClN4O3
References
– [1]Uchii M, et al. Effect of KW-8232, a novel anti-osteoporotic agent, on bone loss in sciatic neurectomized rats. Jpn J Pharmacol. 1998 Oct;78(2):241-3.|[2]Shiwei Wang, et al. A Transferable Deep Learning Approach to Fast Screen Potent Antiviral Drugs against SARS-CoV-2. bioRxiv. 2020.
CAS Number
– 170365-25-0
Molecular Weight
– 609.16
Compound Purity
– 95.0
SMILES
– O=C(C(N1CCN(C)C)=C(C(C2=CC=C(O)C=C2)C3=CC=C(O)C=C3)C4=C1C=CC=C4)N5CCN(C6=CC=CC=C6Cl)CC5
Clinical Information
– No Development Reported
Research Area
– Metabolic Disease; Endocrinology
Solubility
– 10 mM in DMSO
Target
– Prostaglandin Receptor;SARS-CoV
Isoform
– EP
Pathway
– Anti-infection;GPCR/G Protein
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.